| Record ID | marc_university_of_toronto/uoft.marc:58361275:978 |
| Source | University of Toronto |
| Download Link | /show-records/marc_university_of_toronto/uoft.marc:58361275:978?format=raw |
LEADER: 00978cam 22002530i 4500
008 841011s1984 quc a b 1 1 eng d
333 $a 840901135
020 $a0919821057 :$c$35.00
046 $aCaOONL$beng
050 4 $aRE992H88$bN38 1983
055 12 $aRE992*
055 00 $aRE992 H88 $bN38 1984
082 0 $a617.7/1$z19
090 8 $aRE 992 .H88N38 1983$bGERSTM$c1
111 20 $aNational Ophthalmic Speakers Programme$d(1983 :$cMontréal, Quebec, etc.)
245 10 $aProceedings of National Ophthalmic Speakers Programme (NOSP) from the 1983 NOSP series :$bMontreal, Toronto, Vancouver /$cedited by Don Boyaner.
260 0 $aMontréal :$bMedicopea,$c1984.
300 $axii, 97 p. :$bill.
504 $aIncludes bibliographies.
650 0 $aEye$xSurgery
650 0 $aHyaluronic acid$xTherapeutic use
700 10 $aBoyaner, Don
948 $a07/15/1992$b08/03/2001
949 $aRE992 .H88 N38 1983$wLC$c1$i31761010499135$d20/9/1996$lSTACKS$mGERSTEIN$n1$q1$rY$sY$tBOOK$u26/8/1992